Procter & Gamble Health Ltd Financials

Procter & Gamble Health Ltd Financial Statement

Procter & Gamble Health Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	316.69	286.01	254.75
Operating Expense	199.37	255.82	185.04
Net Profit	82.33	16.78	46.56
Net Profit Margin	26.00	5.87	18.28
Earning Per Share	49.60	9.50	28
EBIDTA	116.20	36.93	69.85
Effective Tax Rate	23.82	42.37	23.38

Particulars	Sep 2024
Revenue	316.69
Operating Expense	199.37
Net Profit	82.33
Net Profit Margin	26.00
Earning Per Share	49.60
EBIDTA	116.20
Effective Tax Rate	23.82

Procter & Gamble Health Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Jun 2024	Jun 2023	Jun 2022
Total Revenue Annual	1,151.26	1,229.62	1,114.41
Operating Expenses Annual	845.26	904.94	846.73
Operating Profit Annual	301.44	343.07	280.87
Interest Annual	0.72	0.77	0.42
Depreciation	27.40	28.10	27.08
Net Profit Annual	200.98	229.47	192.52
Tax Annual	72.34	84.73	60.85

Particulars	Jun 2024
Total Revenue Annual	1,151.26
Operating Expenses Annual	845.26
Operating Profit Annual	301.44
Interest Annual	0.72
Depreciation	27.40
Net Profit Annual	200.98
Tax Annual	72.34

Procter & Gamble Health Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Jun 2024	Jun 2023	Jun 2022
Cash Flow at the Beginning	435.42	319.40	464.05
Cash Flow from Operations	228.28	236.01	169.52
Cash Flow from Investing	-6.87	-21.50	-25.54
Cash Flow from Financing	-418.10	-98.49	-288.63
Cash Flow at the End	238.73	435.42	319.40

Particulars	Jun 2024
Cash Flow at the Beginning	435.42
Cash Flow from Operations	228.28
Cash Flow from Investing	-6.87
Cash Flow from Financing	-418.10
Cash Flow at the End	238.73

Procter & Gamble Health Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Jun 2024	Jun 2023	Jun 2022
PBDIT Margin (%)	26.18	27.90	25.20
PBIT Margin (%)	23.80	25.62	22.77
PBT Margin (%)	-9.26	-7.65	-31.45
Net PROFIT Margin (%)	17.46	18.66	17.28
Return On Networth / Equity (%)	31.18	33.56	29.17
Return On Networth /Employed (%)	39.76	43.16	35.97
Return On Assets (%)	29.15	31.54	27.30
Total Debt / Equity (X)	0.02	0.01	0.01
Asset Turnover Ratio (%)	1.67	1.69	1.58

Particulars	Jun 2024
PBDIT Margin (%)	26.18
PBIT Margin (%)	23.80
PBT Margin (%)	-9.26
Net PROFIT Margin (%)	17.46
Return On Networth / Equity (%)	31.18
Return On Networth /Employed (%)	39.76
Return On Assets (%)	29.15
Total Debt / Equity (X)	0.02
Asset Turnover Ratio (%)	1.67

Procter & Gamble Health Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Jun 2024	Jun 2023	Jun 2022
Fixed Assets Annual	126.60	141.72	109.06
Total Current Assets Annual	524.22	796.10	608.04
Non Current Assets Annual	270.14	305.09	280.08
Total Shareholders Funds Annual	538.24	750.89	616.49
Total Assets Annual	794.36	1,101.19	888.12

Particulars	Jun 2024
Fixed Assets Annual	126.60
Total Current Assets Annual	524.22
Non Current Assets Annual	270.14
Total Shareholders Funds Annual	538.24
Total Assets Annual	794.36

Procter & Gamble Health Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Procter & Gamble Health Ltd has a market capitalization of 8,382.75 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Procter & Gamble Health Ltd is debt-free with a debt-to-equity ratio of 0.02.

In FY 2023 , Procter & Gamble Health Ltd recorded a total revenue of approximately 1,151.26 Cr marking a significant milestone in the company's financial performance.

Procter & Gamble Health Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.0% annually, respectively..

Procter & Gamble Health Ltd's current PE ratio is 41.71.

Procter & Gamble Health Ltd's ROCE averaged 44.1% from the FY ending March 2022 to 2024, with a median of 41.3%. It peaked at 50.0% in March 2024, reflecting strong capital efficiency over the period..

Procter & Gamble Health Ltd's latest EBIT is Rs. 274.04 Cr, surpassing the average EBIT of Rs. 280.93 Cr over the 5 years..